BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8278212)

  • 1. Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray.
    Robertson JA; Bodnar RJ
    Pain; 1993 Oct; 55(1):71-84. PubMed ID: 8278212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and hypothermic crosstolerance between continuous and intermittent cold-water swims in rats.
    Pavlovic Z; Bodnar RJ
    Physiol Behav; 1993 Dec; 54(6):1081-4. PubMed ID: 8295944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
    Pavlovic ZW; Cooper ML; Bodnar RJ
    Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
    Campion KN; Saville KA; Morgan MM
    Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
    Tortorici V; Nogueira L; Salas R; Vanegas H
    Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray.
    Hough LB; Nalwalk JW
    Brain Res; 1992 Aug; 588(1):58-66. PubMed ID: 1356588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat.
    Haghparast A; Ahmad-Molaei L
    Neurosci Lett; 2009 Feb; 451(2):165-9. PubMed ID: 19146915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of gp120 on morphine's antinociceptive and neurophysiological actions.
    Chen X; Kirby LG; Palma J; Benamar K; Geller EB; Eisenstein TK; Adler MW
    Brain Behav Immun; 2011 Oct; 25(7):1434-43. PubMed ID: 21569838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray.
    Morgan MM; Whitney PK; Gold MS
    Brain Res; 1998 Aug; 804(1):159-66. PubMed ID: 9729359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray.
    Urban MO; Smith DJ
    Brain Res; 1994 Jul; 652(1):9-16. PubMed ID: 7953726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons.
    Tortorici V; Morgan MM
    J Neurophysiol; 2002 Oct; 88(4):1707-15. PubMed ID: 12364500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
    Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibition selectively potentiates swim stress antinociception in rats.
    Spinella M; Bodnar RJ
    Pharmacol Biochem Behav; 1994 Mar; 47(3):727-33. PubMed ID: 7516079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat.
    Tortorici V; Robbins CS; Morgan MM
    Behav Neurosci; 1999 Aug; 113(4):833-9. PubMed ID: 10495091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinociception.
    Loyd DR; Morgan MM; Murphy AZ
    Neuroscience; 2007 Jun; 147(2):456-68. PubMed ID: 17540508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia and antinociceptive activity of thyrotropin-releasing hormone and morphine following central administration in rats.
    Zhukov VN; Yakimova KS; Shamyakina IY
    Acta Physiol Pharmacol Bulg; 1988; 14(2):18-23. PubMed ID: 3146885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induced by non-opioid analgesic microinjections into rat's periaqueductal gray and nucleus raphe.
    Tsiklauri N; Nozadze I; Gurtskaia G; Berishvili V; Abzianidze E; Tsagareli M
    Georgian Med News; 2010 Mar; (180):47-55. PubMed ID: 20413817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
    Morgan MM; Tran A; Wescom RL; Bobeck EN
    Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray.
    Urban MO; Smith DJ
    J Pharmacol Exp Ther; 1993 May; 265(2):580-6. PubMed ID: 8496808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
    Kanarek RB; Mandillo S; Wiatr C
    Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.